Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, tolerability and pharmacokinetics of BI 764198 in Japanese healthy male subjects
jRCT2071200055Phase 1Not yet recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing BI 764198 arm with Placebo arm (2 arms). Primary endpoint: Percentage of subjects with drug-related adverse events. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
apecotrep
Beyond the preview
Go deeper on jRCT2071200055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200055.